Prevalence of psychiatric disorders in patients with polycystic ovary syndrome

被引:72
作者
Rassi, Arabella [1 ]
Veras, Andre Barciela [1 ]
dos Reis, Moema [1 ]
Pastore, Daniele Lauriano [1 ]
Bruno, Leandro Marchetti [1 ]
Bruno, Ricardo Vasconcellos [1 ]
Pinto de Avila, Marcio Augusto [1 ]
Nardi, Antonio E. [1 ]
机构
[1] Univ Fed Rio de Janeiro, INCT Translat Med CNPq, Inst Psychiat, Panic & Respirat Lab, BR-79020011 Rio De Janeiro, Brazil
关键词
BIPOLAR DISORDER; INSULIN-RESISTANCE; WOMEN; TESTOSTERONE; DEPRESSION; RISK;
D O I
10.1016/j.comppsych.2010.02.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To investigate the prevalence of psychiatric disorders among women in ambulatory treatment for polycystic ovary syndrome (PCOS) and to correlate its clinical and demographic aspects with mental disorders. Methodology: Seventy-two patients in ambulatory treatment at the Endocrinal and Gynaecological Institute of the Federal University of Rio de Janeiro were evaluated using Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition criteria by means of MINI (Mini International Neuropsychiatric Interview, version 4.4). Polycystic ovary syndrome was confirmed according to the ultrasonographic criteria of Adams and by clinical parameters. Results: Forty-one patients (57%) presented at least one psychiatric diagnosis. Among them, the prevalence of mood disorder reached 78%. The most prevalent diagnostics were major depression (26.4%) and bipolar disorder (11.1%). Conclusion: A high prevalence of mental disorders was observed, especially major depression and bipolar disorder. The data obtained regarding the relationship between PCOS and mood disorders in a Brazilian sample is in accordance with recent research findings in the same area. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:599 / 602
页数:4
相关论文
共 50 条
  • [31] Serum irisin levels in patients with polycystic ovary syndrome
    Bostanci, M. S.
    Akdemir, N.
    Cinemre, B.
    Cevrioglu, A. S.
    Ozden, S.
    Unal, O.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (23) : 4462 - 4468
  • [32] Is Apelin a New Biomarker in Patients With Polycystic Ovary Syndrome?
    Dravecka, Ingrid
    Figurova, Jana
    Lazurova, Ivica
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S635 - S641
  • [33] Prevalence of polycystic ovary syndrome in adolescents
    Christensen, Shawna B.
    Black, Mary Helen
    Smith, Ning
    Martinez, Mayra M.
    Jacobsen, Steve J.
    Porter, Amy H.
    Koebnick, Corinna
    FERTILITY AND STERILITY, 2013, 100 (02) : 470 - 477
  • [34] Mood disorders and quality of life in polycystic ovary syndrome
    Podfigurna-Stopa, Agnieszka
    Luisi, Stefano
    Regini, Cristina
    Katulski, Krzysztof
    Centini, Gabriele
    Meczekalski, Blazej
    Petraglia, Felice
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (06) : 431 - 434
  • [35] Impaired olfactory function in patients with polycystic ovary syndrome
    Koseoglu, Sezen Bozkurt
    Koseoglu, Sabri
    Deveer, Ruya
    Derin, Serhan
    Kececioglu, Mehmet
    Sahan, Murat
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2016, 32 (06) : 313 - 316
  • [36] Differentiating Polycystic Ovary Syndrome from Adrenal Disorders
    Yesiladali, Mert
    Yazici, Melis G. K.
    Attar, Erkut
    Kelestimur, Fahrettin
    DIAGNOSTICS, 2022, 12 (09)
  • [37] The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis
    Khorshidi, Ali
    Azami, Milad
    Tardeh, Samira
    Tardeh, Zeinab
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2747 - 2753
  • [38] Metabolic syndrome and polycystic ovary syndrome
    Sobstyl, Malgorzata
    Tkaczuk-Wlach, Joanna
    Sobstyl, Jacek
    Jakiel, Grzegorz
    PRZEGLAD MENOPAUZALNY, 2011, 10 (01): : 74 - 78
  • [39] Gender diversity in adolescents with polycystic ovary syndrome
    Schweisberger, Cintya L.
    Hornberger, Laurie
    Barral, Romina
    Burke, Charles
    Paprocki, Emily
    Sherman, Ashley
    Vanden Brink, Heidi
    Burgert, Tania S.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 35 (11) : 1422 - 1428
  • [40] Are patients with polycystic ovary syndrome more prone to irritable bowel syndrome?
    Kaluzna, Malgorzata
    Kompf, Pola
    Wachowiak-Ochmanska, Katarzyna
    Moczko, Jerzy
    Krolczyk, Aleksandra
    Janicki, Adam
    Szapel, Karol
    Grzymislawski, Marian
    Ruchala, Marek
    Ziemnicka, Katarzyna
    ENDOCRINE CONNECTIONS, 2022, 11 (04)